| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ART.1780401105 |
| P698 | PubMed publication ID | 9365082 |
| P50 | author | Richard O. Day | Q47104529 |
| P2093 | author name string | J S Walker | |
| Richard O. Day | |||
| Judith S. Walker | |||
| J J Carmody | |||
| J H Vial | |||
| R B Sheather-Reid | |||
| Janet H. Vial | |||
| John J. Carmody | |||
| Rachel B. Sheather-Reid | |||
| P2860 | cites work | Analgesic efficacy of non-steroidal anti-inflammatory drugs in experimental pain in humans | Q34345634 |
| Clinical response to non-steroidal anti-inflammatory drugs in urate-crystal induced inflammation: a simultaneous study of intersubject and intrasubject variability | Q34346200 | ||
| Variability in response to nonsteroidal anti-inflammatory analgesics: evidence from controlled clinical therapeutic trial of flurbiprofen in rheumatoid arthritis | Q34418215 | ||
| Variations in responses to non-steroidal anti-inflammatory drugs | Q34511202 | ||
| Variations in response to non-steroidal anti-inflammatory drugs | Q41905119 | ||
| Anti-inflammatory analgesic drug responders and non-responders: a clinico-pharmacological study of flurbiprofen | Q41990007 | ||
| P433 | issue | 11 | |
| P921 | main subject | osteoarthritis | Q62736 |
| immunology | Q101929 | ||
| rheumatoid arthritis | Q187255 | ||
| rheumatology | Q327657 | ||
| P304 | page(s) | 1944-1954 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | Arthritis and Rheumatism | Q23929027 |
| P1476 | title | Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis: support for the concept of "responders" and "nonresponders" | |
| Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis. Support for the concept of “responders” and “nonresponders” | |||
| P478 | volume | 40 |
| Q37358290 | A measure of treatment response: patient and physician satisfaction with traditional NSAIDs for osteoarthritis control |
| Q34240778 | Celecoxib: a new option in the treatment of arthropathies and familial adenomatous polyposis |
| Q33937522 | Choosing the right nonsteroidal anti-inflammatory drug for the right patient: a pharmacokinetic approach |
| Q34108696 | Clinical assessment and significance of inflammation in knee osteoarthritis |
| Q37199724 | Clinical efficacy of certain Unani herbs in knee osteoarthritis: A pretest and post-test evaluation study |
| Q33882627 | Clinical pharmacokinetics and pharmacodynamics of celecoxib: a selective cyclo-oxygenase-2 inhibitor |
| Q36120809 | Clinical pharmacology of lumiracoxib, a second-generation cyclooxygenase 2 selective inhibitor |
| Q46905204 | Comparison of prednisolone with piroxicam in complex regional pain syndrome following stroke: a randomized controlled trial |
| Q37900856 | Definition of nonresponse to analgesic treatment of arthritic pain: an analytical literature review of the smallest detectable difference, the minimal detectable change, and the minimal clinically important difference on the pain visual analog scale |
| Q46115750 | Diclofenac and ketoprofen liver toxicity in rat. |
| Q47968062 | Discovery of distinctive gene expression profiles in rheumatoid synovium using cDNA microarray technology: evidence for the existence of multiple pathways of tissue destruction and repair |
| Q39167580 | Effects of Pregabalin in Patients with Neuropathic Pain Previously Treated with Gabapentin: A Pooled Analysis of Parallel-Group, Randomized, Placebo-controlled Clinical Trials |
| Q37302467 | Effects of dietary supplementation with the solanaceae plant alkaloid anatabine on joint pain and stiffness: results from an internet-based survey study |
| Q80059887 | Failures in a proton pump inhibitor therapeutic substitution program: lessons learned |
| Q47240445 | Gastrointestinal bleeding associated with chronic excessive use overdosing with topical ketoprofen patch in elderly patient |
| Q39315179 | Guidelines for the use of nonsurgical interventions in osteoarthritis management |
| Q37634998 | Is osteoarthritis a heterogeneous disease that can be stratified into subsets? |
| Q37341156 | NSAIDs: learning new tricks from old drugs |
| Q33944084 | Osteoarthritis of the hand: a modifiable disease. |
| Q26826917 | Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome |
| Q36110592 | Pharmacogenetics of analgesic drugs |
| Q24289028 | Progress in genetic studies of pain and analgesia |
| Q37523942 | The treatment and prevention of knee osteoarthritis: a tool for clinical decision-making. |
| Q33542921 | The use of analgesics in the management of pain in rheumatic diseases |
| Q39437816 | Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: a randomized, double-blind, placebo-controlled study |
| Q28353468 | Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine |
Search more.